Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Non-Current Debt (2017 - 2018)

Autolus Therapeutics (AUTL) has disclosed Non-Current Debt for 2 consecutive years, with $380000.0 as the latest value for Q3 2018.

  • For the quarter ending Q3 2018, Non-Current Debt fell 50.2% year-over-year to $380000.0, compared with a TTM value of $380000.0 through Sep 2018, down 50.2%, and an annual FY2018 reading of $380000.0, down 50.2% over the prior year.
  • Non-Current Debt was $380000.0 for Q3 2018 at Autolus Therapeutics, down from $763000.0 in the prior quarter.
  • Across five years, Non-Current Debt topped out at $763000.0 in Q3 2017 and bottomed at $380000.0 in Q3 2018.